Gain Therapeutics GANX
NASDAQ GANX
$1.98 -0.09 (-4.35%)
At close: Aug 20, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Receivables - Net (2020 - 2026)

Gain Therapeutics (GANX) posted quarterly Receivables - Net of $763606.0 for Q1 2026, up 19.51% year-over-year from $638961.0 in Q1 2025, and up 47.67% quarter-over-quarter from $517094.0 in Q3 2025.

Gain Therapeutics (GANX) Receivables - Net (2020 - 2026) Analysis & Trends

Gain Therapeutics' Receivables - Net history runs 5 years deep, the most recent figure standing at $763606.0 for Q1 2026.

  • In Q1 2026, Receivables - Net rose 19.51% year-over-year to $763606.0; the TTM figure through Mar 2026 stood at $763606.0 (up 19.51% YoY), while the FY2025 annual figure was $622992.0, up 25.94% from the prior year.
  • Receivables - Net for Q1 2026 stood at $763606.0, up from $517094.0 in the prior quarter.
  • The five-year high for Receivables - Net was $1.1 million in Q2 2025, with the low at $494684.0 in Q4 2024.
  • The 3-year median for Receivables - Net is $638961.0 (2025), against an average of $702145.6.
  • Peak annual rise in Receivables - Net reached 19.51% in 2026, while the deepest fall reached 19.51% in 2026.
  • Gain Therapeutics' Receivables - Net stood at $494684.0 in 2024, then climbed by 4.53% to $517094.0 in 2025, then soared by 47.67% to $763606.0 in 2026.
  • Business Quant data shows GANX's Receivables - Net at $763606.0 in Q1 2026, $517094.0 in Q3 2025, and $1.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Gain Therapeutics 85.12 Mn 85.12 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 821,212.00
Jun 30, 2026 821,212.00
Mar 31, 2026 763,606.00
Mar 31, 2026 763,606.00
Sep 30, 2025 517,094.00
Sep 30, 2025 517,094.00
Jun 30, 2025 1.10 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 638,961.00
Mar 31, 2025 638,961.00
Dec 31, 2024 494,684.00
Dec 31, 2024 494,684.00
Sep 30, 2021 24,713.00
Sep 30, 2021 24,713.00
Jun 30, 2021 353,166.00
Jun 30, 2021 353,166.00
Mar 31, 2021 4,486.00
Mar 31, 2021 4,486.00
Dec 31, 2020 8,548.00
Dec 31, 2020 8,548.00